Your browser doesn't support javascript.
loading
Ethanol-Gel Sclerotherapy of Venous Malformations: Effectiveness and Safety.
Teusch, Veronika I; Wohlgemuth, Walter A; Hammer, Simone; Piehler, Armin P; Müller-Wille, René; Goessmann, Holger; Uller, Wibke.
Afiliação
  • Teusch VI; 1 Department of Radiology, University Medical Center Regensburg, 93042 Regensburg, Germany.
  • Wohlgemuth WA; 1 Department of Radiology, University Medical Center Regensburg, 93042 Regensburg, Germany.
  • Hammer S; 1 Department of Radiology, University Medical Center Regensburg, 93042 Regensburg, Germany.
  • Piehler AP; 2 Fürst Medical Laboratory, Oslo, Norway.
  • Müller-Wille R; 3 Present address: Bioscientia Institute for Medical Diagnostics GmbH, Karlsfeld, Germany.
  • Goessmann H; 1 Department of Radiology, University Medical Center Regensburg, 93042 Regensburg, Germany.
  • Uller W; 1 Department of Radiology, University Medical Center Regensburg, 93042 Regensburg, Germany.
AJR Am J Roentgenol ; 209(6): 1390-1395, 2017 Dec.
Article em En | MEDLINE | ID: mdl-28929808
ABSTRACT

OBJECTIVE:

In the treatment of venous malformations, ethanol may be administered in a gelified form to increase local effects and reduce systemic ones. The purpose of this prospective study was to evaluate the efficacy and safety of a commercially available viscous ethanol gel in the treatment of venous malformations. SUBJECTS AND

METHODS:

Thirty-one patients (mean age, 23.4 years; age range, 6.6-46.5 years) with venous malformations were prospectively scheduled for two ethanol-gel sclerotherapy sessions. Venous malformations were located at the lower extremity (n = 18), the upper extremity (n = 9), and the face (n = 4). Questionnaires to assess pain, clinical examinations, professional photographs, and contrast-enhanced MRI of the venous malformations were performed before and after therapy to measure therapy-induced changes. Two experienced radiologists blinded to the examination date and clinical status compared photographs and MR images before and after treatment.

RESULTS:

A mean of 4.2 mL of ethanol gel were administered per session. The technical success rate was 100%. Clinical success, defined as improvement or resolution of symptoms, was noted in 81% of patients. Mean pain score decreased, and the difference was statistically significant (3.9 vs 3.1, p = 0.005). In 54 treatment sessions where follow-up was available, four minor complications occurred. Comparison of photographs and MR images before and after treatment showed improvement in 35% and 93% of patients, respectively.

CONCLUSION:

Ethanol gel is an effective and safe sclerosing agent in the treatment of venous malformations.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Soluções Esclerosantes / Escleroterapia / Etanol / Malformações Vasculares / Géis Tipo de estudo: Observational_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: AJR Am J Roentgenol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Soluções Esclerosantes / Escleroterapia / Etanol / Malformações Vasculares / Géis Tipo de estudo: Observational_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: AJR Am J Roentgenol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha